Real-World Methotrexate Dose on Clinical Effectiveness and Structural Damage of Certolizumab Pegol With Rheumatoid Arthritis.
- DOI
- 10.3389/fmed.2021.643459
- Published
- 2021
- Container
- Frontiers in medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fmed.2021.643459,
title = {Real-World Methotrexate Dose on Clinical Effectiveness and Structural Damage of Certolizumab Pegol With Rheumatoid Arthritis.},
author = {Nozaki Y and Hidaka T and Ri J and Itami T and Tomita D and Okada A and Ashida C and Ikeda F and Yamamoto A and Funahashi K and Kinoshita K and Matsubara T and Funauchi M and Matsumura I},
year = {2021},
journal = {Frontiers in medicine},
doi = {10.3389/fmed.2021.643459},
url = {https://doi.org/10.3389/fmed.2021.643459}
}RIS
TY - JOUR TI - Real-World Methotrexate Dose on Clinical Effectiveness and Structural Damage of Certolizumab Pegol With Rheumatoid Arthritis. AU - Nozaki Y AU - Hidaka T AU - Ri J AU - Itami T AU - Tomita D AU - Okada A AU - Ashida C AU - Ikeda F AU - Yamamoto A AU - Funahashi K AU - Kinoshita K AU - Matsubara T AU - Funauchi M AU - Matsumura I PY - 2021 JO - Frontiers in medicine DO - 10.3389/fmed.2021.643459 UR - https://doi.org/10.3389/fmed.2021.643459 ER -
APA
Y, N., T, H., J, R., T, I., D, T., A, O., C, A., F, I., A, Y., K, F., K, K., T, M., M, F., & I, M. (2021). Real-World Methotrexate Dose on Clinical Effectiveness and Structural Damage of Certolizumab Pegol With Rheumatoid Arthritis.. Frontiers in medicine. https://doi.org/10.3389/fmed.2021.643459